Treatment Planning

The greatest potential benefit of interim FDG PET/CT evaluation is the potential to inform "response-adapted therapy," whereby treatment could be de-escalated in intensity in the setting of a satisfactory early response or escalated if early response is inadequate.⁴

Products

LOGIQ™ E10 Ultrasound Series

Next-generation, leadership ultrasound that adapts to your needs, today and into the future. Choose from a wide array of advanced imaging tools and robust productivity enhancers based on artificial intelligence—all on a scalable platform that lets you configure your system specifically to the needs of your practice.

Take advantage of our most technologically-advanced ultrasound ever to bring fast, precise, consistent imaging to your patients—your way— with the LOGIQ E10 Series.
Revolution CT
Get uncompromised image quality and clinical capabilities through the convergence of coverage, spatial resolution, temporal resolution and spectral imaging.
MR Radiation Oncology Suite
Our MR Radiation Oncology Suite provides the tools designed to help you better target and treat tumors through consistent patient positioning.

4. Imaging for Staging and Response Assessment in Lymphoma. Sarah A. Johnson , Anita Kumar, Matthew J. Matasar, Heiko Schöder, Jürgen Rademaker. Published Online:Jul 23 2015https://doi.org/10.1148/radiol.2015142088. https://pubs.rsna.org/doi/full/10.1148/radiol.2015142088